1. US Centers for Disease Control and Prevention. Vaccine Adverse Event Reporting System (VAERS) standard operating procedures for covid-19 (as of 29 January 2021). Jan 2021. https://www.cdc.gov/vaccinesafety/pdf/VAERS-v2-SOP.pdf
2. US Centers for Disease Control and Prevention. Vaccine Adverse Event Reporting System (VAERS) standard operating procedures for covid-19 (as of 2 February 2022). Feb 2022. https://www.cdc.gov/vaccinesafety/pdf/VAERS-COVID19-SOP-02-02-2022-508.pdf
3. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
4. Pfizer. 5.3.6 Cumulative analysis of post-authorization adverse event reports of PF-07302048 (BNT162b2) received through 28-Feb-2021. Apr 2021. https://phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf
5. Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose